(secondQuint)A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate (ALG-1001) as Compared to Avastin and Focal Laser Photocoagulation in the Treatment of Diabetic Macular Edema.

 To evaluate the safety and efficacy of Luminate(R) (ALG-1001) as compared to Avastin(R) and focal laser photocoagulation in patients with diabetic macular edema - 150 eligible subjects with DME will be enrolled and randomized to one of 5 treatment groups, i.

e.

, one of three doses of Luminate intravitreal injection or Avastin intravitreal injection or focal laser photocoagulation.

 Subjects will be followed monthly for 24 weeks (6 months).

 A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate (ALG-1001) as Compared to Avastin and Focal Laser Photocoagulation in the Treatment of Diabetic Macular Edema@highlight

A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate(R) (ALG-1001) as Compared to Avastin(R) and Focal Laser Photocoagulation in the Treatment of Diabetic Macular Edema